adenosine: be contraindicated in wpw

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents molecule
Weight: 0.61
, neurotransmitter
Weight: 0.57
, compound
Weight: 0.54
, purine
Weight: 0.51
, vasodilator
Weight: 0.50
Siblings adenosine triphosphate
Weight: 0.40
, acetylcholine
Weight: 0.37
, rna molecule
Weight: 0.37
, dna molecule
Weight: 0.36
, serotonin
Weight: 0.36

Related properties

Property Similarity
be contraindicated in wpw 1.00
be contraindicated in asthma 0.94
be contraindicated in fibrillation 0.93
be contraindicated in atrial fibrillation 0.86

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.26
Rule weight: 0.28
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.07
Plausible(adenosine, be contraindicated in wpw)
Evidence: 0.07
¬ Salient(adenosine, be contraindicated in wpw)

Similarity expansion

0.63
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.94
Evidence: 0.06
Remarkable(adenosine, be contraindicated in wpw)
Evidence: 0.23
¬ Remarkable(adenosine, be contraindicated in asthma)
0.55
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.94
Evidence: 0.07
Salient(adenosine, be contraindicated in wpw)
Evidence: 0.33
¬ Salient(adenosine, be contraindicated in asthma)
0.45
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.86
Evidence: 0.06
Remarkable(adenosine, be contraindicated in wpw)
Evidence: 0.41
¬ Remarkable(adenosine, be contraindicated in atrial fibrillation)
0.44
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.94
Evidence: 0.07
Plausible(adenosine, be contraindicated in wpw)
Evidence: 0.48
¬ Plausible(adenosine, be contraindicated in asthma)
0.44
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.93
Evidence: 0.06
Remarkable(adenosine, be contraindicated in wpw)
Evidence: 0.47
¬ Remarkable(adenosine, be contraindicated in fibrillation)
0.40
Rule weight: 0.85
Evidence weight: 0.50
Similarity weight: 0.94
Evidence: 0.30
Typical(adenosine, be contraindicated in wpw)
Evidence: 0.71
¬ Typical(adenosine, be contraindicated in asthma)
0.35
Rule weight: 0.85
Evidence weight: 0.44
Similarity weight: 0.93
Evidence: 0.30
Typical(adenosine, be contraindicated in wpw)
Evidence: 0.80
¬ Typical(adenosine, be contraindicated in fibrillation)
0.26
Rule weight: 0.85
Evidence weight: 0.35
Similarity weight: 0.86
Evidence: 0.30
Typical(adenosine, be contraindicated in wpw)
Evidence: 0.92
¬ Typical(adenosine, be contraindicated in atrial fibrillation)
0.26
Rule weight: 0.85
Evidence weight: 0.33
Similarity weight: 0.93
Evidence: 0.07
Plausible(adenosine, be contraindicated in wpw)
Evidence: 0.72
¬ Plausible(adenosine, be contraindicated in fibrillation)
0.25
Rule weight: 0.85
Evidence weight: 0.32
Similarity weight: 0.93
Evidence: 0.07
Salient(adenosine, be contraindicated in wpw)
Evidence: 0.73
¬ Salient(adenosine, be contraindicated in fibrillation)
0.18
Rule weight: 0.85
Evidence weight: 0.24
Similarity weight: 0.86
Evidence: 0.07
Salient(adenosine, be contraindicated in wpw)
Evidence: 0.81
¬ Salient(adenosine, be contraindicated in atrial fibrillation)
0.17
Rule weight: 0.85
Evidence weight: 0.23
Similarity weight: 0.86
Evidence: 0.07
Plausible(adenosine, be contraindicated in wpw)
Evidence: 0.82
¬ Plausible(adenosine, be contraindicated in atrial fibrillation)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.07
Salient(adenosine, be contraindicated in wpw)
Evidence: 0.30
¬ Typical(adenosine, be contraindicated in wpw)
Evidence: 0.06
¬ Remarkable(adenosine, be contraindicated in wpw)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.07
Plausible(adenosine, be contraindicated in wpw)
Evidence: 0.30
¬ Typical(adenosine, be contraindicated in wpw)